Search

everythinglearnresearchcommunity

for

Search:↓

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Minoxidil foam enters hair follicles and skin for hair growth.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Laser and light treatments can effectively remove hair long-term.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Finasteride effectively treats central serous chorioretinopathy.

Microneedling may help hair loss, but needs more research.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Medications for PCOS don't seem to raise heart disease risk.

Inducing ferroptosis in hepatic stellate cells is crucial for treating liver fibrosis.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.